{"symbol":"VRTX","fiscalQuarter":"Q2-2019","reportDate":"2019-07-31","reportTime":"AMC","status":"reported","company":{"name":"Vertex Pharmaceuticals Incorporated","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/VRTX/earnings/Q2-2019","postBrief":{"headline":"Vertex Pharmaceuticals Beats on EPS, Stock Down 1.72%","keyNumbers":[{"metric":"EPS","actual":"$1.26","expected":"N/A","surprise":"+13.15%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record for the earnings call, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available for this quarter.","changes":[]},"whatItMeans":"Vertex Pharmaceuticals reported a better-than-expected EPS, which indicates strong earnings performance. However, the stock fell by 1.72% following the announcement, suggesting that investors may have been looking for more comprehensive information or guidance that was not provided.","metaDescription":"Vertex Pharmaceuticals (VRTX) Q2 2019 earnings: EPS beat by 13.15%. Stock down 1.72%. Full breakdown."}}